Immune checkpoint inhibitors like anti-PD-1 have transformed melanoma treatment, yet more than half of patients fail to ...

Agricultural scientists are rethinking their battle plans against plant parasites that cause billions of dollars in annual ...

A common probiotic bacterium, Bifidobacterium animalis, secretes mannose—a simple sugar—that significantly suppresses melanoma growth in mice by ...

The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...

BiTAC® is a registered trademark of VERAXA Biotech GmbH.

Genmab A/S(Nasdaq: GMAB) announced today that the European Commission (EC) granted marketing authorization for TEPKINLY ® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R 2 ) ...

Approval of pediatric strategy validates clinical data package and accelerates the regulatory path for CORDStrom™ in the United KingdomBOCA ...

MHRA minutes from May 12 pre-MAA Scientific Advice meeting confirm agreement across all questions covering CMC, non-clinical and clinical ...

Data demonstrate favorable safety and tolerability profile, robust B-cell depletion, and encouraging platelet responses in heavily pretreated patients with primary immune thrombocytopenia Enrollment ...

Araris Biotech AG, a company advancing a differentiated pipeline of antibody-drug conjugates (“ADCs”) therapies, and Taiho Oncology, Inc., a company developing and commercializing novel treatments for ...

Researchers at Karolinska Institutet have uncovered how serotonin-related metabolism helps regulate an understudied immune ...

Traditional therapeutics target the inactive conformation of proteins, allowing tumors to adapt and resume signaling.